MARKET

MRNA

MRNA

Moderna
NASDAQ

Real-time Quotes | Nasdaq Last Sale

18.59
+0.36
+1.97%
After Hours: 21.94 +3.35 +18.02% 19:59 02/24 EST
OPEN
19.23
PREV CLOSE
18.23
HIGH
19.28
LOW
18.30
VOLUME
6.34M
TURNOVER
--
52 WEEK HIGH
29.79
52 WEEK LOW
11.54
MARKET CAP
6.03B
P/E (TTM)
-11.5638
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MRNA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average MRNA stock price target is 29.78 with a high estimate of 40.00 and a low estimate of 24.00.

EPS

MRNA News

More
  • Moderna Ships mRNA Vaccine Against Novel Coronavirus (mRNA-1273) for Phase 1 Study
  • Business Wire · 1h ago
  • Moderna delivers first coronavirus vaccine for human testing
  • CNBC.com · 2h ago
  • Moderna Stock Rockets As It Plans To Test Coronavirus Vaccine
  • Investor's Business Daily · 2h ago
  • Moderna to Present at Upcoming Investor Conferences
  • Business Wire · 11h ago

Industry

Biotechnology & Medical Research
-2.96%
Pharmaceuticals & Medical Research
-2.86%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About MRNA

Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another three have open INDs. Its therapeutics and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. It has created six modalities prophylactic vaccines, cancer vaccines, intratumoral immmuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics and systemic intracellular therapeutics.
More

Webull offers kinds of Moderna Inc stock information, including NASDAQ:MRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRNA stock news, and many more online research tools to help you make informed decisions.